A Prospective, Multicenter, Randomized Controlled Clinical Study on the Safety and Efficacy of Biolimus Drug-Coated Balloon (DCB) Versus Drug-Eluting Stent (DES) in the Treatment of De Novo Coronary Artery Lesions
NCT:NCT07582250 · NOT_YET_RECRUITING
廣告
NCT IDNCT07582250
狀態NOT_YET_RECRUITING
SponsorJW Medical Systems Ltd (INDUSTRY)
First posted
Last updated
簡要摘要
To compare the safety and efficacy of Biolimus drug-coated balloon (DCB) versus drug-eluting stent (DES) in the treatment of de novo coronary artery lesions.
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。